Cite

HARVARD Citation

    Negrier, S. et al. (n.d.). 870PDEfficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). Annals of oncology. p. . [Online]. 
  
Back to record